Depth of coverage and heterogeneity of the mutation loci. x-axis, mutation loci in sample set one or two; y-axis, depth of coverage after UMI consolidation. by Lizhi Yu (12476136)

Subjects:

Impact of mutation type on VAF quantification performance. by Lizhi Yu (12476136)

Subjects:

Schematic overview of the cross-platform study. by Lizhi Yu (12476136)

Subjects:

Impact of DNA extraction process on depth of coverage. by Lizhi Yu (12476136)

Subjects:

Blocking C5L2 decreased C5a-primed neutrophils expression of membrane-bound PR3 (mPR3). by Jian Hao (160736)

NCM treatment decreases hepatic CoQ₁₀, but increases total cholesterol and cholesterol ester levels, which is associated with significant decreases in the expressions of... by Ryan J. Mailloux (50825)

Internalized oAβ puncta colocalize with lysosomes in NG and HG mixed glia cultures. by Yung-Cheng Huang (3443450)

Confocal images of oAβ internalization by astrocytes in NG and HG mixed glia cultures. by Yung-Cheng Huang (3443450)

CyaA decreases the capacity of TLR-stimulated DCs to present soluble antigen to CD4⁺ T cells. by Irena Adkins (173166)

Exposure to LPS decreases insulin, PDX-1 and MafA gene expression in isolated islets via TLR4. by Julie Amyot (167960)

Mov10 decreases specific infectivity of HIV-1. by Vyacheslav Furtak (253807)

Overexpression of Mov10 decreases HIV-1 infectivity. by Vyacheslav Furtak (253807)

RhoC overexpression in MCF10A cells results in a decrease in WISP3 mRNA level by Celina G Kleer (2440)

“…</p> Reverse transcriptase polymerase chain reaction was conducted on vector and MCF10A cells stably overexpressing RhoC. RhoC-overexpressing cells had decreased levels of WISP3 mRNA.…”

Kisspeptin-10 decreases blood flow in the peripheral vasculature. by Iain Sawyer (356468)

Mammalian METTL10 is an EF1A1 KMT. by Tadahiro Shimazu (619411)

Subjects:

Represents the levels of biomarkers as baseline and follow up in placebo and cholecalciferol group. by Jaskiran Kaur (160829)

MCP-1-deficiency decreased CD11c-expressing cells via impairing the production of ROS and decreased activation of PLCγ2, Akt, and ERK upon M-CSF stimulation in BMM. by Woon-Ki Kim (447798)

“…<p>BMMs from WT (open bar) and MCP-1-KO mice (oblique-lined bar) were incubated in the presence of M-CSF (30 ng/ml) with U73122 (10 µM), Akt inhibitor IV (0.3 µM), PD098059 (5 µM), DPI (50 nM), NAC (3 mM), or H₂O₂ (300 µM) for 4 d (A). *, <i>P</i><0.05; ***, <i>P</i><0.001 compared with vehicle-treated WT cells. …”

Measurement of mitochondrial superoxide anion production in HL-1 cells exposed for 12 or 72h to LG, NG, HG or IHG. by Patrick Mordel (17020879)

Activator A10 increases and inhibitor G8 decreases the rate of PMA-induced PKCε-EGFP translocation in HeLa cells. by Milla Summanen (325769)

Subjects:

Effects of ROCK inhibitors H-1152 and Y-27632 on TNF-induced MLC phosphorylation, actin and CL5 reorganization and the fall in TEER. by Paul R. Clark (714064)

“…D) Effects of H-1152 and Y-27632 on the phase 1 and phase 2 TEER decreases induced by TNF. Starting at T₀, HDMEC plated on ECIS 96-well arrays received a 1 hour pre-treatment with vehicle (top panel, n = 4, 4) or with a ROCK inhibitor, either H-1152 (at 1 or 10 μM, middle panel, n = 6, 6) or Y-27632 (at 1 or 10 μM, bottom panel, n = 6, 6). …”